Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.244.20.2286PMID 7001056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary rehabilitation in an ambulatory group practice setting.

  1979cited by this paper
• Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients.

  1978cited by this paper
• Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease: noninvasive assessment by radionuclide angiocardiography.

  1978cited by this paper
• Response to corticosteroids in chronic bronchitis.

  1978cited by this paper
• Choosing a drug regimen for obstructive pulmonary disease. 1. Agents to achieve bronchodilatation.

  1978cited by this paper
• Effect of respiratory drugs on mucociliary clearance.

  1978cited by this paper
• Rehabilitation of patients with chronic obstructive pulmonary disease.

  1976cited by this paper
• Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

  1976cited by this paper
• Theophylline-induced seizures in adults. Correlation with serum concentrations.

  1975cited by this paper
• Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.

  1974cited by this paper
• Tracheal mucous velocity in normal man and patients with obstructive lung disease: effects of terbutaline.

  1974cited by this paper
• Rational intravenous doses of theophylline.

  1973cited by this paper
• The use of non-parametric methods in the statistical analysis of the two-period change-over design.

  1972cited by this paper
• Pharmacologic effects of intravenously administered aminophylline in asthmatic children.

  1970cited by this paper

• improvement in the treatment of CAO.

  2017cites this paper
• L’efficacité des médicaments en situation réelle dans le traitement des maladies respiratoires et la dualité entre l’assurance médicaments privée et publique face à l’adhésion et la persistance à ces traitements

  2015cites this paper
• Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease.

  2015cites this paper
• The Study of Efficacy, Tolerability and Safety of Theophylline Given Along with Formoterol Plus Budesonide in COPD.

  2015cites this paper
• Bronchodilators in Chronic Air-Flow Limitation

  2015cites this paper
• Nonpulmonary influences on gas exchange.

  2014cites this paper
• The Pharmacological Approach to the Elderly COPD Patient

  2013cites this paper
• Erratum to: Reliability and validity of the Taiwan (Mandarin Chinese) version of the chronic respiratory questionnaire

  2011cites this paper
• Reliability and validity of the Taiwan (Mandarin Chinese) version of the chronic respiratory questionnaire

  2011cites this paper
• Chronic Bronchitis and Emphysema

  2010cites this paper
• A critique of dosing strategies for beta-2 adrenergic agents and theophylline

  2007cites this paper
• Use of theophylline in chronic obstructive pulmonary disease: examining the evidence

  2006cites this paper
• A meta-analysis on the efficacy of oral theophylline in patients with stable COPD

  2006cites this paper
• Avaliação do teste de caminhada dos seis minutos e do teste de função pulmonar em pacientes submetidos ao transplante pulmonar

  2005cites this paper
• Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2005cites this paper
• Maintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approach

  2005cites this paper
• [Health-related quality of life measurement: a readers' guide].

  2004cites this paper
• Qualité de vie liée à la santé : un guide de lecture

  2004cites this paper
• [Health-related quality of life measurement: a critical reading guide].

  2003cites this paper
• Oral theophylline for chronic obstructive pulmonary disease.

  2002cites this paper
• Using Simple and Relative Difference to Interpret Changes in Health-Related Quality-of-Life Scores for Salmeterol, Ipratropium, and Placebo

  2000cites this paper
• Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice.

  1999cites this paper
• Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group.

  1998cites this paper
• Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease

  1998cites this paper
• Is there really a controversy surrounding the effectiveness of respiratory rehabilitation in COPD?

  1998cites this paper
• Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice.

  1998cites this paper
• Health Status Measurement Instruments in Chronic Obstructive Pulmonary Disease

  1997cites this paper
• Quality of life in female lung transplant candidates and recipients.

  1997cites this paper
• The use of bronchodilators in stable chronic obstructive pulmonary disease.

  1997cites this paper
• Current thoughts regarding treatment of chronic obstructive pulmonary disease.

  1996cites this paper
• Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants.

  1995cites this paper
• The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.

  1995cites this paper
• Symptomatic Bronchodilator Treatment

  1995cites this paper
• Theophylline a and s selective P PDE iinhibitors a as bronchodilators a and s smooth m muscle rrelaxants

  1995cites this paper
• Chronic pulmonary disease in the trauma patient.

  1994cites this paper
• Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.

  1993cites this paper
• Review of the clinical efficacy of theophylline in the treatment of chronic obstructive pulmonary disease.

  1993cites this paper
• Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease.

  1993cites this paper
• Theophylline in the ambulatory treatment of chronic obstructive lung disease: resolving a controversy.

  1993cites this paper
• Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease.

  1992cites this paper
• Effect of theophylline in chronic obstructive lung disease.

  1992cites this paper
• Chronic Obstructive Airways Disease

  1992cites this paper
• [Plasma concentrations of theophylline in patients with chronic obstructive pulmonary disease. What therapeutic limit should be used?].

  1992cites this paper
• Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.

  1992cites this paper
• Pharmacology of Anti-Asthma Xanthines

  1991cites this paper
• Comparative assessment of enprofylline and theophylline for chronic obstructive airways disease in the elderly.

  1990cites this paper
• Aminophylline in the outpatient management of decompensated chronic obstructive pulmonary disease.

  1990cites this paper
• Use of Serum Theophylline Level as a Guide to Optimum Therapy in Patients with Chronic Obstructive Lung Disease

  1990cites this paper
• The Effect of Theophylline on Respiratory Muscle Contractility and Fatigue

  1990cites this paper
• Management of asthma and chronic airflow limitation. Are methylxanthines obsolete?

  1990cites this paper
• The relationship between pulmonary function and dyspnea in obstructive lung disease.

  1989cites this paper
• Therapeutic Monitoring of Theophylline

  1989cites this paper
• Reversing the irreversible.

  1989cites this paper
• Therapeutic Drug Monitoring in the Long-Term Care Facility

  1989cites this paper
• Response to bronchodilators.

  1989cites this paper
• Theophylline and the respiratory muscles: where are we?

  1989cites this paper
• Effect of inhaled metaproterenol on exercise performance in patients with stable "fixed" airway obstruction.

  1988cites this paper
• Acute Response to Bronchodilator: An Imperfect Guide for Bronchodilator Therapy in Chronic Airflow Limitation

  1988cites this paper
• Guide to Therapy with Theophylline for the Treatment of Obstructive Lung Disease

  1988cites this paper
• Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation.

  1988cites this paper
• Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction.

  1988cites this paper
• The use of theophylline in 'irreversible' chronic obstructive pulmonary disease. An update.

  1988cites this paper
• Measuring health status in chronic airflow limitation.

  1988cites this paper
• Dose response relation to oral theophylline in severe chronic obstructive airways disease.

  1988cites this paper
• Clinical Experience with Two Twice Daily Slow Release Theophylline Preparations. Relation between Serum Theophylline Concentrations, Effectiveness, Tolerability and Compliance in Elderly Patients

  1987cites this paper
• Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.

  1987cites this paper
• Treatment of Chronic Obstructive Pulmonary Disease with Two Sustained-Release Theophylline Preparations

  1987cites this paper
• A measure of quality of life for clinical trials in chronic lung disease.

  1987cites this paper
• Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease.

  1987cites this paper
• Theophylline as a bronchodilator in COPD and its combination with inhaled beta-adrenergic drugs.

  1987cites this paper
• The role of theophylline in the treatment of dyspnea in COPD.

  1987cites this paper
• Clinical Use of Controlled-Release Theophylline in Chronic Airways Obstruction

  1987cites this paper
• Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disease.

  1986cites this paper
• Measuring disease-specific quality of life in clinical trials.

  1986cites this paper
• Theophylline in chronic obstructive pulmonary disease.

  1986cites this paper
• Serum theophylline and phenytoin levels: can we afford to do them? Can we afford not to?

  1986cites this paper
• Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction.

  1986cites this paper
• Effects of theophylline on cardiovascular performance in chronic obstructive pulmonary disease.

  1985cites this paper
• The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.

  1985cites this paper
• How should we measure function in patients with chronic heart and lung disease?

  1985cites this paper
• Aminophylline and mucociliary clearance in patients with irreversible airflow limitation.

  1985cites this paper
• The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.

  1985cites this paper
• Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.

  1985cites this paper
• Aminophylline and its influence on ventilatory endurance in humans.

  1985cites this paper
• Rapid assay of serum theophylline levels.

  1985cites this paper
• The pendulum swings again. Toward a rational use of theophylline.

  1985cites this paper
• Update on the pharmacodynamics and pharmacokinetics of theophylline.

  1985cites this paper
• Theophylline and chronic obstructive pulmonary disease.

  1984cites this paper
• Theophylline in stable chronic airflow obstruction. A reappraisal.

  1984cites this paper
• Bronchodilator therapy in chronic airflow obstruction.

  1984cites this paper
• Pharmacology and therapeutic use of theophylline.

  1984cites this paper
• Theophylline and chronic obstructive pulmonary disease.

  1984cites this paper
• Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease.

  1984cites this paper
• Effect of inhaled atropine or metaproterenol in patients with chronic airway obstruction and therapeutic serum theophylline levels.

  1984cites this paper
• The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking.

  1984cites this paper
• Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease.

  1984cites this paper
• Slow release theophyllines and chronic bronchitis.

  1984cites this paper
• Therapy of Chronic Obstructive Airways Disease

  1984cites this paper
• The pharmacology and therapeutic use of theophylline.

  1984cites this paper
• Oral theophylline intoxication. A serious error of patient and physician understanding.

  1984cites this paper